Aims and scope
Multiple Sclerosis and Demyelinating Disorders publishes high-quality, original, basic, and clinical research in the field of multiple sclerosis, neuromyelitis optica and all other demyelinating diseases of the central nervous system.
Main areas of interest include: biochemistry, epidemiology, genetics, health services research, molecular biology, neuroimaging, neuroimmunology, neurology, neuropathology, neuropsychology, neurorehabilitation, pharmacology, physiology, political science, protein chemistry, psychiatry, public policy, sociology, and therapeutics.
The Journal also focuses on areas of research underrepresented in the existing literature, such as the economics and sustainability of multiple sclerosis clinical care, the role of advanced nursing on clinical care of demyelinating disorders, and the impact of stakeholder’s associations on the management of multiple sclerosis.
2016 Journal Metrics
68 days from submission to first decision
26 days from acceptance to publication
735.0 Usage Factor
Social Media Impact